RivoceranibVarious toxicities: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1694卷 / 1期

关键词：

D O I：

10.1007/s40278-018-43787-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：386 / 386

相关论文

共 50 条

[31] RivoceranibVarious toxicities and development of resistance: case report
Reactions Weekly, 2019, 1737 (1) : 258 - 258
[32] RivoceranibVarious toxicites: 4 case reports
Reactions Weekly, 2019, 1774 (1) : 283 - 283
[33] Programmed-cell-death-1-receptor-antagonists/rivoceranibVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1833 (1) : 331 - 331
[34] Osimertinib/rivoceranibVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1871 (1) : 336 - 336
[35] ImmunosuppressantsVarious toxicities: 2 case reports: 2 case reports
Reactions Weekly, 2019, 1769 (1) : 253 - 253
[36] RivoceranibVarious toxicity and lack of efficacy: 16 case reports
Reactions Weekly, 2023, 1986 (1) : 393 - 393
[37] Gimeracil/oteracil/tegafur/imatinib/rivoceranibVarious toxicities: case report
Reactions Weekly, 2021, 1858 (1) : 171 - 171
[38] Camrelizumab/Potassium-chloride/RivoceranibVarious toxicities: case report
Reactions Weekly, 2025, 2041 (1) : 93 - 93
[39] RiociguatVarious toxicities: 2 case reports
Reactions Weekly, 2018, 1728 (1) : 316 - 316
[40] AntineoplasticsVarious toxicities: 2 case reports
Reactions Weekly, 2020, 1796 (1) : 35 - 35

← 1 2 3 4 5 →